Vol 15, No 5 (2019)
CURRENT LITERATURE REVIEW
Published online: 2019-10-30
Get Citation

Current literature review

Maciej Kawecki
Oncol Clin Pract 2019;15(5).
Vol 15, No 5 (2019)
CURRENT LITERATURE REVIEW
Published online: 2019-10-30

Abstract

x

Abstract

x

Get Citation
About this article
Title

Current literature review

Journal

Oncology in Clinical Practice

Issue

Vol 15, No 5 (2019)

Published online

2019-10-30

Bibliographic record

Oncol Clin Pract 2019;15(5).

Authors

Maciej Kawecki

References (5)
  1. Kopetz S, Grothey A, Yaeger R, et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer. N Engl J Med. 2019; 381(17): 1632–1643.
  2. Hellmann M, Paz-Ares L, Caro RB, et al. Nivolumab plus ipilimumab in advanced non–small-cell lung cancer. N Engl J Med. 2019.
  3. Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. N Engl J Med. 2018; 378(22): 2093–2104.
  4. Coleman R, Fleming G, Brady M, et al. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. N Engl J Med. 2019.
  5. González-Martín A, Pothuri B, Vergote I, et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2019.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl